1.
J Pediatric Infect Dis Soc
; 2024 Aug 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-39149792
RESUMO
Post-artesunate delayed hemolysis (PADH) occurred in 6 of 24 children treated with artesunate for severe malaria in the United States; however severe hemolysis requiring hospitalization or transfusion was rare. In children in the U.S. treated with artesunate, counseling and symptom monitoring may be preferred to weekly laboratory surveillance for PADH.